60882-73-7

Basic information

• Product Name: 1H-Benzimidazole-1,2-diamine,5,6-dimethyl-(9CI)
• Synonyms: 1H-Benzimidazole-1,2-diamine,5,6-dimethyl-(9CI);Nsc286692
• CAS NO: 60882-73-7
• Molecular Formula: C9H12N4
• Molecular Weight: 176.21838
• Product Categories: BENZIMIDAZOLE
• Mol File: 60882-73-7.mol
• Article Data: 2

Chemical Properties

• Melting Point: 292-294 °C(Solv: ethanol (64-17-5))
• Boiling Point: 424.9°C at 760 mmHg
• Flash Point: 210.8°C
• Appearance: /
• Density: 1.37g/cm³
• Vapor Pressure: 1.99E-07mmHg at 25°C
• Refractive Index: 1.7
• PKA: 6.85±0.10(Predicted)
• CAS DataBase Reference: 1H-Benzimidazole-1,2-diamine,5,6-dimethyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Benzimidazole-1,2-diamine,5,6-dimethyl-(9CI)(60882-73-7)
• EPA Substance Registry System: 1H-Benzimidazole-1,2-diamine,5,6-dimethyl-(9CI)(60882-73-7)

Safety Data

• Hazardous Substances Data: 60882-73-7(Hazardous Substances Data)

Usage

General Description

1H-Benzimidazole-1,2-diamine,5,6-dimethyl-(9CI) is a chemical compound with the molecular formula C9H12N4. It is a derivative of benzimidazole and diamine, and is also known by its systematic name 5,6-dimethyl-1H-benzimidazole-1,2-diamine. 1H-Benzimidazole-1,2-diamine,5,6-dimethyl-(9CI) is commonly used in pharmaceutical research for its potential biological activities. It has been studied for its potential antineoplastic and antihypertensive properties, and has been investigated as a potential lead compound for the development of new drugs. Additionally, 1H-Benzimidazole-1,2-diamine,5,6-dimethyl-(9CI) has also been used as a chemical intermediate in the synthesis of other organic compounds.

InChI:InChI=1/C9H12N4/c1-5-3-7-8(4-6(5)2)13(11)9(10)12-7/h3-4H,11H2,1-2H3,(H2,10,12)

Upstream product

• 29096-75-1 2-amino-5,6-dimethylbenzimidazole 

Relevant articles and documents

Method of inhibiting the advanced glycosylation of proteins using 1,2-disubstituted-benzimidazoles

The present invention relates to compositions and methods for inhibiting nonenzymatic cross-linking (protein aging). Accordingly, composition is disclosed which comprises 1,2-disubstituted benzimidazoles capable of inhibiting the formation of advanced glycosylation endproducts of target proteins by reacting with the carbonyl moiety of the early glycosylation product of such target proteins formed by their initial glycosylation. The method comprises contacting the target protein with the composition. Both industrial and therapeutic applications for the invention are envisioned, as food spoilage and animal protein aging can be treated.